<DOC>
	<DOCNO>NCT00182403</DOCNO>
	<brief_summary>FIDO multicentred randomize , open-label trial compare fixed-dose UFH fixed-dose LMWH initial treatment VTE . Patients follow 3 month receive warfarin ( target INR 2.0-3.0 ) .</brief_summary>
	<brief_title>Fixed Dose Heparin Study</brief_title>
	<detailed_description>The general objective simplify reduce cost treatment acute venous thromboembolism ( VTE ) .Specific objective compare efficacy , safety cost effectiveness unfractionated heparin ( UFH ) low molecular weight heparin ( LMWH ) administer subcutaneously ( sc ) , twice daily , weight -adjusted , fixed dos ; determine anticoagulant response ( anti-Factor Xa heparin level , APTT result ) influence efficacy safety UFH LMWH , independently dose .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>A diagnosis acute venous thromboembolism ( VTE , DVT /or PE ) Contraindication subcutaneous ( sc ) route administration ( eg : shock ( evidence poor peripheral perfusion ) , major surgery within 48 hour ) Active Bleeding process Comorbid condition limit expect survival le 3 month Current treatment therapeutic dose UFH , LMWH , danaparoid sodium , direct thrombin inhibitor 48 hour Currently long term warfarin heparin therapy Allergy heparin history heparin induce thrombocytopenia Currently pregnant Contraindication contrast medium ( eg : allergy creatinine &gt; 200 umol/L ) . Currently enrol enrol compete study Geographically inaccessible followup assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Unfractionated Heparin</keyword>
	<keyword>Low Molecular Weight Heparin</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>APTT</keyword>
	<keyword>Treatment</keyword>
</DOC>